JPH10511677A - イノシトール三燐酸の薬剤調製への使用 - Google Patents
イノシトール三燐酸の薬剤調製への使用Info
- Publication number
- JPH10511677A JPH10511677A JP8520899A JP52089996A JPH10511677A JP H10511677 A JPH10511677 A JP H10511677A JP 8520899 A JP8520899 A JP 8520899A JP 52089996 A JP52089996 A JP 52089996A JP H10511677 A JPH10511677 A JP H10511677A
- Authority
- JP
- Japan
- Prior art keywords
- hydrogen
- inositol
- tumor
- cells
- phosphate group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. イノシトール三燐酸(IP3)の少なくとも1つの異性体の、転移抑制効 果を有する薬剤の調製への使用。 2. イノシトール三燐酸(IP3)の少なくとも1つの異性体の、腫瘍組織増 殖及び腫瘍組織の血管形成を予防し、緩和し、又は抑制するための薬剤の調製へ の使用。 3. 神経膠腫の治療への請求項1に記載の使用。 4. 上記イノシトール三燐酸の異性体が塩の形態をとっている、請求項1乃至 3のいずれか1つに記載の使用。 5. 上記イノシトール三燐酸が、ナトリウム、カリウム、カルシウム、又は亜 鉛の塩となっている、請求項4に記載の使用。 6. 上記薬剤が、錠剤、顆粒剤、カプセル、溶液又は懸濁液を含む単位剤形を とっている、請求項1乃至5のいずれか1つに記載の使用。 7. 上記イノシトール三燐酸が、D−ミオ−イノシトール−1,2,6−三燐 酸である、請求項1乃至6のいずれか1つに記載の使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9404568A SE9404568L (sv) | 1994-12-30 | 1994-12-30 | Användning av inositoltrisfosfat för beredning av läkemedel |
SE9404568-9 | 1994-12-30 | ||
PCT/SE1995/001585 WO1996020715A1 (en) | 1994-12-30 | 1995-12-22 | The use of inositoltrisphosphate for the preparing of medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH10511677A true JPH10511677A (ja) | 1998-11-10 |
Family
ID=20396521
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8520899A Pending JPH10511677A (ja) | 1994-12-30 | 1995-12-22 | イノシトール三燐酸の薬剤調製への使用 |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0794786B1 (ja) |
JP (1) | JPH10511677A (ja) |
AT (1) | ATE247474T1 (ja) |
AU (1) | AU4361996A (ja) |
DE (1) | DE69531554T2 (ja) |
SE (1) | SE9404568L (ja) |
WO (1) | WO1996020715A1 (ja) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005511725A (ja) * | 2001-12-13 | 2005-04-28 | バイタル ヘルス サイエンシズ プロプライアタリー リミティド | 化合物の経皮輸送 |
US8841342B2 (en) | 2002-08-09 | 2014-09-23 | Vital Health Sciences Pty. Ltd. | Carrier |
US9168216B2 (en) | 2005-06-17 | 2015-10-27 | Vital Health Sciences Pty. Ltd. | Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof |
US9314527B2 (en) | 2010-03-30 | 2016-04-19 | Phosphagenics Limited | Transdermal delivery patch |
US9561243B2 (en) | 2011-03-15 | 2017-02-07 | Phosphagenics Limited | Composition comprising non-neutralised tocol phosphate and a vitamin A compound |
US10071030B2 (en) | 2010-02-05 | 2018-09-11 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
US10973761B2 (en) | 2015-12-09 | 2021-04-13 | Phosphagenics Limited | Pharmaceutical formulation |
US11753435B2 (en) | 2016-12-21 | 2023-09-12 | Avecho Biotechnology Limited | Process |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3336583A1 (de) * | 1983-09-26 | 1985-04-25 | Udo Dr. 8400 Regensburg Ehrenfeld | Erzeugnis zur diagnose und therapie von malignen tumoren |
US4952396A (en) * | 1986-11-19 | 1990-08-28 | Linus Pauling Institute Of Science & Medicine | Method of using phytic acid for inhibiting tumor growth |
-
1994
- 1994-12-30 SE SE9404568A patent/SE9404568L/ not_active Application Discontinuation
-
1995
- 1995-12-22 WO PCT/SE1995/001585 patent/WO1996020715A1/en active IP Right Grant
- 1995-12-22 DE DE69531554T patent/DE69531554T2/de not_active Expired - Fee Related
- 1995-12-22 EP EP95942373A patent/EP0794786B1/en not_active Expired - Lifetime
- 1995-12-22 JP JP8520899A patent/JPH10511677A/ja active Pending
- 1995-12-22 AT AT95942373T patent/ATE247474T1/de not_active IP Right Cessation
- 1995-12-22 AU AU43619/96A patent/AU4361996A/en not_active Abandoned
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005511725A (ja) * | 2001-12-13 | 2005-04-28 | バイタル ヘルス サイエンシズ プロプライアタリー リミティド | 化合物の経皮輸送 |
US8841342B2 (en) | 2002-08-09 | 2014-09-23 | Vital Health Sciences Pty. Ltd. | Carrier |
US9168216B2 (en) | 2005-06-17 | 2015-10-27 | Vital Health Sciences Pty. Ltd. | Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof |
US10071030B2 (en) | 2010-02-05 | 2018-09-11 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
US9314527B2 (en) | 2010-03-30 | 2016-04-19 | Phosphagenics Limited | Transdermal delivery patch |
US9561243B2 (en) | 2011-03-15 | 2017-02-07 | Phosphagenics Limited | Composition comprising non-neutralised tocol phosphate and a vitamin A compound |
US10188670B2 (en) | 2011-03-15 | 2019-01-29 | Phosphagenics Limited | Composition |
US10973761B2 (en) | 2015-12-09 | 2021-04-13 | Phosphagenics Limited | Pharmaceutical formulation |
US11753435B2 (en) | 2016-12-21 | 2023-09-12 | Avecho Biotechnology Limited | Process |
Also Published As
Publication number | Publication date |
---|---|
SE9404568L (sv) | 1996-07-01 |
WO1996020715A1 (en) | 1996-07-11 |
SE9404568D0 (sv) | 1994-12-30 |
DE69531554D1 (de) | 2003-09-25 |
ATE247474T1 (de) | 2003-09-15 |
AU4361996A (en) | 1996-07-24 |
DE69531554T2 (de) | 2004-06-17 |
EP0794786A1 (en) | 1997-09-17 |
EP0794786B1 (en) | 2003-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6153603A (en) | Method of treating angiogenesis in tumor tissue | |
US6284786B1 (en) | Treatment of cancer using lipoic acid in combination with ascorbic acid | |
JP5026408B2 (ja) | 泌尿生殖器癌及びその転移の治療を意図した、亜ヒ酸、そのナトリウム塩、及びその誘導体を含む製薬組成物 | |
EP3311841B1 (en) | Anticancer agent | |
US8551967B2 (en) | Formulations with anti-tumour action | |
KR100861428B1 (ko) | 암 치료용 지방산 유사체 | |
KR20020087456A (ko) | 혈관 손상 활성을 지닌 조합 요법 | |
AU2001242581A1 (en) | Combination therapies with vascular damaging activity | |
CN112043834A (zh) | 一种负载顺铂的纤维蛋白胶复合体系 | |
Vali et al. | Intraarterial therapy with a new potent inhibitor of tumor metabolism (3-bromopyruvate): identification of therapeutic dose and method of injection in an animal model of liver cancer | |
US6255291B1 (en) | Composition and method for treating cancer and immunological disorders resulting in chronic conditions | |
JPH10511677A (ja) | イノシトール三燐酸の薬剤調製への使用 | |
Bleday et al. | Inhibition of rat colon tumor isograft growth with dequalinium chloride | |
US20190160099A1 (en) | Pharmaceutical composition and use thereof | |
JP2019520310A (ja) | 癌及び前癌病変に対する治療剤、治療方法、及び治療薬剤製造方法 | |
CN106974908A (zh) | 含有hdac抑制剂和ire1抑制剂的药物组合物及用途 | |
CN106727479B (zh) | 多取代萘衍生物在制备抗肿瘤血管生成药物中的应用及药物组合物 | |
Horsman et al. | The ability of nicotinamide to inhibit the growth of a C3H mouse mammary carcinoma | |
Franchi et al. | Elevated doses of carmustine and mitomycin C, with lonidamine enhancement and autologous bone marrow transplantation in the treatment of advanced colorectal cancer: results from a pilot study | |
CN107412736A (zh) | 一种抗肿瘤联合用药物及其在制备抗癌药物中的用途 | |
JPWO2006035515A1 (ja) | 膀胱表在性癌の治療又は予防用医薬組成物、及びその利用 | |
RU2279277C2 (ru) | Лечение разделенными дозами агентов с сосудоразрушающей активностью | |
JPH0460093B2 (ja) | ||
WO1997023229A1 (en) | The use of an ester of inositoltrisphosphate for the preparing of medicaments | |
CA1319107C (en) | Formulations for inhibiting glucose transport |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD12 | Notification of acceptance of power of sub attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7432 Effective date: 20060711 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20061205 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20070228 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20070416 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070605 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070807 |